Ms4a7 expression in cDC1s determines cross-presentation and anti-tumor immunity
ChIP-seq / ATAC-seq (genome binding and open chromatin) · mouse · 40 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Mus musculus (mouse)
- Samples
- 40 samples: 20 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE255477_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1075093 and SRA study SRP489153. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 40 samples.
How we read this: 20 replicated groups read from 40 sample titles; they account for 40 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8073005 dLN GFP-nAPCs_rep1 dLN GFP-nAPCs
- GSM8073006 dLN GFP-nAPCs_rep2 dLN GFP-nAPCs
- GSM8073007 dLN GFP-cDCs_rep1 dLN GFP-cDCs
- GSM8073008 dLN GFP-cDCs_rep2 dLN GFP-cDCs
- GSM8073009 dLN GFP+nAPCs_rep1 dLN GFP+nAPCs
- GSM8073010 dLN GFP+nAPCs_rep2 dLN GFP+nAPCs
- GSM8073011 dLN GFP+cDCs_rep1 dLN GFP+cDCs
- GSM8073012 dLN GFP+cDCs_rep2 dLN GFP+cDCs
- GSM8073013 TME GFP-nAPCs_rep1 TME GFP-nAPCs
- GSM8073014 TME GFP-nAPCs_rep2 TME GFP-nAPCs
- GSM8073015 TME GFP-cDCs_rep1 TME GFP-cDCs
- GSM8073016 TME GFP-cDCs_rep2 TME GFP-cDCs
- GSM8073017 TME GFP+nAPCs_rep1 TME GFP+nAPCs
- GSM8073018 TME GFP+nAPCs_rep2 TME GFP+nAPCs
- GSM8073019 TME GFP+cDCs_rep1 TME GFP+cDCs
- GSM8073020 TME GFP+cDCs_rep2 TME GFP+cDCs
- GSM8073021 WT_C1_PBS_rep1 WT_C1_PBS
- GSM8073022 WT_C1_PBS_rep2 WT_C1_PBS
- GSM8073023 WT_C1_LPS_rep1 WT_C1_LPS
- GSM8073024 WT_C1_LPS_rep2 WT_C1_LPS
- GSM8073025 WT_C2_PBS_rep1 WT_C2_PBS
- GSM8073026 WT_C2_PBS_rep2 WT_C2_PBS
- GSM8073027 WT_C2_LPS_rep1 WT_C2_LPS
- GSM8073028 WT_C2_LPS_rep2 WT_C2_LPS
- GSM8073029 KO_C1_PBS_rep1 KO_C1_PBS
- GSM8073030 KO_C1_PBS_rep2 KO_C1_PBS
- GSM8073031 KO_C1_LPS_rep1 KO_C1_LPS
- GSM8073032 KO_C1_LPS_rep2 KO_C1_LPS
- GSM8073033 KO_C2_PBS_rep1 KO_C2_PBS
- GSM8073034 KO_C2_PBS_rep2 KO_C2_PBS
- GSM8073035 KO_C2_LPS_rep1 KO_C2_LPS
- GSM8073036 KO_C2_LPS_rep2 KO_C2_LPS
- GSM8073037 C1_PBS_rep1 C1_PBS
- GSM8073038 C1_PBS_rep2 C1_PBS
- GSM8073039 C1_LPS_rep1 C1_LPS
- GSM8073040 C1_LPS_rep2 C1_LPS
- GSM8073041 C2_PBS_rep1 C2_PBS
- GSM8073042 C2_PBS_rep2 C2_PBS
- GSM8073043 C2_LPS_rep1 C2_LPS
- GSM8073044 C2_LPS_rep2 C2_LPS
- GSE311148 CD200+ CD8 T Cell Generated through Arginine Deprivation to Activate Macrophage Cross-presentation and Improve Anti-Tumor Immunity [RNA-Seq 2] 10 samples shares cross-presentation, anti-tumor, immunity
- GSE311146 CD200+ CD8 T Cell Generated through Arginine Deprivation to Activate Macrophage Cross-presentation and Improve Anti-Tumor Immunity [RNA-Seq] 10 samples shares cross-presentation, anti-tumor, immunity
- GSE284315 Viral-directed augmentation of Kupffer cell cross-presentation provokes anti-tumor immunity against liver metastasis 6 samples shares cross-presentation, anti-tumor, immunity
- GSE311149 CD200+ CD8 T Cell Generated through Arginine Deprivation to Activate Macrophage Cross-presentation and Improve Anti-Tumor Immunity [scRNA-Seq] 2 samples shares cross-presentation, anti-tumor, immunity
- GSE311145 CD200+ CD8 T Cell Generated through Arginine Deprivation to Activate Macrophage Cross-presentation and Improve Anti-Tumor Immunity [ATAC-Seq] 2 samples shares cross-presentation, anti-tumor, immunity
- GSE309514 Sex determines the Natural Killer cell-mediated immunity against Pancreatic Cancer. 22 samples shares determines, immunity
- GSE270915 The expression order determines the pioneer functions of Ngn3 and NeuroD1 in pancreatic endocrine differentiation 3745 samples shares determines
- GSE326200 Absence of Clec1a in murine cDC1s decrease IFN responses to necrotic cells 237 samples shares cdc1s
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.